Institut CurieYann Kieffer et al.Clinical Interest of Combining Transcriptomic and Genomic Signatures in High-Grade Serous Ovarian CancerFrontiers in Genetics 2020, vol. 11doi: 10.3389/fgene.2020.00219 2020 PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairmentToutes les publicationsLack of evidence for CDK12 as an ovarian cancer predisposing gene
